Sanofi Australia has received
TGA approval for its Zaltrap
(aflibercept rch) in combination
chemotherapy for use in
adults with metastatic colorectal
cancer previously treated with an
oxaliplatin-containing regimen.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 05 Apr 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Apr 13
QUEENSLAND One Nation Senator, Malcolm Roberts, stirred the medicinal cannabis debate in parliament this week claiming the Federal Minister for Health, Greg Hunt, is playing a “pharmaceutical game” with the medicine.